Clinical relevance of the Pulmonary Mycobiome in Non-Cystic Fibrosis Bronchiectasis: The CAMEB study (ATS 2018, San Diego)

High Frequency of Atopy with geographic variation in non-cystic fibrosis bronchiectasis (ATS 2018, San Diego)

In vitro antimicrobial susceptibility testing of clinical and environmental Mycobacterium chimaera isolates (ECCMID 2018, Madrid)

The pulmonary microbiome in non-cystic fibrosis bronchiectasis. (ERS 2017, Milan)

High frequencies of Aspergillus colonization and associated inflammation in stable bronchiectasis (ERS 2017, Milan)

The pulmonary mycobiome in stable bronchiectasis. (ATS 2017, Washington DC)

FindR-TB: A cloud–based tool for antibiotic resistance prediction in Mycobacterium tuberculosis (CERC 2017, Cork, Ireland)

Clostridium difficile induces expansion and cytokine
production by human Vdelta9Vdelta2 T cells (7th International gamma/delta T Cell Conference, London 2016)

First insights into Irish Mycobacterium chimaera isolates (European Society for Mycobacteria 2015, Sardina)

An investigation of ST22-MRSA-IV hospital transmission events using whole-genome sequencing (2014 – poster)

Serum resistance and Extra-intestinal Pathogenic Escherichia coli bloodstream infections (2014 – poster)

Analysis of Clostridium difficile Gene Expression and Intestinal Dysbiosis in a Murine Model of Antibiotic-associated Colitis (2013 – oral presentation)

Investigation of QRDR-independent fluoroquinolone resistance in Irish Clostridum difficile isolates (2012 – poster presentation)